Dr. Reddy’s Laboratories Ltd ADR Cash Flow-to-Debt Ratio
Dr. Reddy’s Laboratories Ltd ADR cash flow-to-debt ratio. Dr. Reddy’s Laboratories Ltd ADR (RDY) has a Cash Flow-to-Debt Ratio of 0.06x as of December 2025, meaning its operating cash flow of $10.91 Billion could theoretically repay 0% of its total liabilities ($187.14 Billion) in one year. Check Dr. Reddy’s Laboratories Ltd ADR cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Dr. Reddy’s Laboratories Ltd ADR (2000–2025)
Cash flow-to-debt ratio of Dr. Reddy’s Laboratories Ltd ADR from 2000 to 2025. Historical debt coverage capacity for Dr. Reddy’s Laboratories Ltd ADR across 26 annual periods. Check RDY cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Dr. Reddy’s Laboratories Ltd ADR Cash Flow-to-Debt Ratio by Year (2000–2025)
Dr. Reddy’s Laboratories Ltd ADR cash flow-to-debt ratio by year from 2000 to 2025. Year-by-year debt coverage analysis for Dr. Reddy’s Laboratories Ltd ADR. For the full cash flow conversion analysis, see Dr. Reddy’s Laboratories Ltd ADR cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | $46.43 Billion | $155.82 Billion | ▼ -29.8% |
| 2024 | 0.42x | $45.43 Billion | $106.97 Billion | ▼ -34.4% |
| 2023 | 0.65x | $58.87 Billion | $90.86 Billion | ▲ +135.8% |
| 2022 | 0.27x | $28.11 Billion | $102.30 Billion | ▼ -99.0% |
| 2021 | 28.24x | $35.70 Billion | $1.26 Billion | ▼ -3.4% |
| 2020 | 29.22x | $29.84 Billion | $1.02 Billion | ▲ +8576.9% |
| 2019 | 0.34x | $28.70 Billion | $85.23 Billion | ▲ +85.2% |
| 2018 | 0.18x | $18.03 Billion | $99.14 Billion | ▼ -19.0% |
| 2017 | 0.22x | $21.51 Billion | $95.78 Billion | ▼ -56.8% |
| 2016 | 0.52x | $41.25 Billion | $79.31 Billion | ▲ +73.4% |
| 2015 | 0.30x | $25.03 Billion | $83.46 Billion | ▲ +22.4% |
| 2014 | 0.25x | $19.46 Billion | $79.42 Billion | ▲ +1174.6% |
| 2013 | 0.02x | $13.32 Billion | $692.64 Billion | ▼ -92.6% |
| 2012 | 0.26x | $16.15 Billion | $62.03 Billion | ▲ +59.3% |
| 2011 | 0.16x | $8.01 Billion | $49.02 Billion | ▼ -53.8% |
| 2010 | 0.35x | $13.23 Billion | $37.41 Billion | ▲ +227.6% |
| 2009 | 0.11x | $4.50 Billion | $41.75 Billion | ▼ -32.4% |
| 2008 | 0.16x | $6.12 Billion | $38.38 Billion | ▼ -40.1% |
| 2007 | 0.27x | $11.83 Billion | $44.44 Billion | ▲ +651.6% |
| 2006 | 0.04x | $1.65 Billion | $46.50 Billion | ▼ -87.1% |
| 2005 | 0.27x | $2.29 Billion | $8.34 Billion | ▼ -61.6% |
| 2004 | 0.72x | $4.01 Billion | $5.59 Billion | ▼ -30.1% |
| 2003 | 1.03x | $4.35 Billion | $4.25 Billion | ▼ -22.7% |
| 2002 | 1.33x | $4.65 Billion | $3.51 Billion | ▲ +1323.6% |
| 2001 | 0.09x | $614.87 Million | $6.60 Billion | ▼ -63.7% |
| 2000 | 0.26x | $14.29 Million | $55.70 Million | — |